A Japanese pharmaceutical company has voluntarily withdrawn a stomach medicine after it was found to be contaminated with a prohibited substance. Sawai Pharmaceuticals has announced that it is voluntarily recalling its Ecabet Sodium Karyu 66.7% Sawai product, a medicine used to treat gastritis and stomach ulcers, after it was found to contain the ingredient acetazolamide, a drug prohibited under anti-doping regulations.
On Mar. 1 the Ministry of Health, Labor and Welfare conclusively determined that a wrestler had tested positive as a direct result of using the Sawai product in question. Sawai Pharmaceuticals said that although there is no health danger in using the product, it is voluntarily withdrawing it because it is unclear at what stage the prohibited substance was included. The company said that it is highly likely the contamination was committed by another company to which it outsources some manufacturing and that it is investigating the situation.
source article:
https://www.fnn.jp/posts/00413389CX
translated by Brett Larner
On Mar. 1 the Ministry of Health, Labor and Welfare conclusively determined that a wrestler had tested positive as a direct result of using the Sawai product in question. Sawai Pharmaceuticals said that although there is no health danger in using the product, it is voluntarily withdrawing it because it is unclear at what stage the prohibited substance was included. The company said that it is highly likely the contamination was committed by another company to which it outsources some manufacturing and that it is investigating the situation.
source article:
https://www.fnn.jp/posts/00413389CX
translated by Brett Larner
Comments